MPLT – maplight therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at Weiss Ratings. They set a "sell (e)" rating on the stock.
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Form 4 MapLight Therapeutics, For: Feb 20 Filed by: Malenka Robert C.
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Form 4 MapLight Therapeutics, For: Feb 18 Filed by: Pavlov George
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.